FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi1, Paolo del Fiore2, Irene Russo2, Chiara Trevisiol2, Marco Domenico Mazza2, Saveria Tropea2, Francesco Russano2, Mauro Alaibac3, Carlomaria Gianesini4, Giovanni Madeo4, Simone Mocellin2|4 | 1Department of Medicine, University of Padua, Padua; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 3Department of Dermatology, University of Padua; 4Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
309 -
Granular cell dermatofibroma: a potential diagnostic pitfall
1002PDF: 556HTML: 157 -
-
18 | Surgical management of pregnancy-associated melanoma: a single institution experience with thirty-three pregnant patients B. Taglione1, I. Mattavelli1, A. Maurichi1, G. Gallino1, D. Cortese1, E. Tolomio1, G. Spadola1, C. Barbieri1, S. Mercurio1, B. Scoppio1, B. Valeri2, M. Cossa2, M. Maccauro3, L. Di Guardo4, M. Del Vecchio4, M. Santinami1, R. Patuzzo1 | 1IRCCS Istituto Nazionale Tumori Milano, Surgery, Milano; 2IRCCS Istituto Nazionale Tumori Milano, Pathology, Milano; 3IRCCS Istituto Nazionale Tumori Milano, Nuclear Medicine, Milano; 4IRCCS Istituto Nazionale Tumori Milano, Medical Oncology, Milano, Italy.
338 -
Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites
1038PDF: 502Supplementary Table: 229HTML: 13 -
Telangiectasia Macularis Eruptiva Perstans: more than skin deep
11687PDF: 2218HTML: 2302 -
Erythema multiforme following Orf viral infection: a comprehensive review of the literature with a case report highlight
3571PDF: 535SUPPLEMENTARY MATERIAL: 186HTML: 74 -
-
CD4/CD8 double-negative mycosis fungoides: a review
3201PDF: 632SUPPLEMENTARY: 113HTML: 23 -
A giant benign clear cell hidradenoma on the anterior trunk
1484PDF: 915HTML: 1039 -
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols
792PDF: 307SUPPLEMENTARY MATERIAL: 79HTML: 4

